Endovascular treatment of common hepatocellular carcinoma: the experience of one center by V.A. Kondratiuk, I.A. Mazanovych

Subjects: “…hepatocellular carcinoma; chemoembolization.…”
Get full text

Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm? by Bernardo Stefanini, Luca Ielasi, Dante Pio Pallotta, Sofia Penazza, Mariarosaria Marseglia, Fabio Piscaglia

“…This review explores the evolution of cancer staging, focusing on intermediate hepatocellular carcinoma (HCC), and the challenges faced by physicians. …”
Get full text

The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes by Asanda Koza, Ricky H. Bhogal, Nicos Fotiadis, Vasileios K. Mavroeidis

Subjects: “…Hepatocellular carcinoma…”
Get full text

Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta‐analysis by Yu Zhang, Juan Tang, Xiao Zhou, Shao‐Liang Zhu, Le‐Qun Li

Subjects: Get full text

Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma by Moritz Peiseler, Frank Tacke

Subjects: Get full text

Hepatocellular carcinoma: immunohistochemical characteristics of apoptosis and cell proliferation activity by Tumanskiy V.A., Zubko M.D.

“…Background. Hepatocellular carcinoma which takes about 85% of primary liver cancer, is the most aggressive and prognostically unfavorable tumor. …”
Get full text

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma by Bang Soo-Mee, Lee Jeong, Park Yeon, Kim Ju, Kim Sun, Kwon Oh, Kwon So, Han Sang, Lee Yuna, Park Se, Cho Eun, Shin Dong, Lee Jae

“…<p>Abstract</p> <p>Background</p> <p>Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed this study with new effective drug combination.…”
Get full text

Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma by Xiaodong Li, Xiaodong Li, Fanguang Meng, Fanguang Meng, Hankang Wang, Hankang Wang, Liwei Sun, Liwei Sun, Shulin Chang, Shulin Chang, Guijie Li, Feng Chen

Subjects: Get full text

Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma by Yang Xie, Runzi Sun, Li Gao, Jibin Guan, Jingyuan Wang, Aaron Bell, Junjie Zhu, Min Zhang, Meishu Xu, Peipei Lu, Xinran Cai, Songrong Ren, Pengfei Xu, Satdarshan P. Monga, Xiaochao Ma, Da Yang, Yulan Liu, Binfeng Lu, Wen Xie

“…However, there was a lack of report on whether and how LXRα plays a role in the development of hepatocellular carcinoma (HCC). In the current study, we found that systemic activation of LXRα in the VP‐LXRα knock‐in (LXRαKI) mice or hepatocyte‐specific activation of LXRα in the VP‐LXRα transgenic mice sensitized mice to liver tumorigenesis induced by the combined treatment of diethylnitrosamine (DEN) and 3,3',5,5'‐tetrachloro‐1,4‐bis (pyridyloxy) benzene (TCPOBOP). …”
Get full text

Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy by Konstantinos Arvanitakis, Triantafyllia Koletsa, Ioannis Mitroulis, Georgios Germanidis

Subjects: Get full text

Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma by Wasitha P.D. Wass Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway

“…Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the second leading cause of cancer-related deaths worldwide. …”
Get full text

Safety of elective hepatectomy performed on weekend for patients with hepatocellular carcinoma by Junlong Dai, Junyi Shen, Xiaoyun Zhang, Wei Peng, Tianfu Wen, Chuan Li, Jing Ni

Get full text

Non-alcoholic fatty liver disease-related hepatocellular carcinoma by Darine Daher, Karim Seif El Dahan, Amit G. Singal

“…Non-alcoholic fatty liver disease (NAFLD), one of the most common causes of liver disease, is an increasingly common cause of hepatocellular carcinoma (HCC). Several demographic, clinical, and genetic factors contribute to HCC risk in NAFLD patients, which may inform risk stratification scores. …”
Get full text

XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance by Sitian Yang, Xiao Qi Wang

“…Here, we investigated the role of XRCC4-like factor (XLF), a core member of the non-homologous end joining (NHEJ) repair pathway, in chemoresistance in hepatocellular carcinoma (HCC). Methods qRT-PCR analysis and western blotting were performed to detect expression levels of genes and proteins related to NHEJ. …”
Get full text

Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma by Victoria Foy, Mairéad G. McNamara, Juan W. Valle, Angela Lamarca, Julien Edeline, Richard A. Hubner

Get full text

Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma by Xiaoyu Liu, Wan Xie, Silu Meng, Xiaoyan Kang, Yuhuan Liu, Lili Guo, Changyu Wang

“…Growing evidence suggests that snoRNAs act as oncogenes or tumor suppressors in hepatocellular carcinoma (HCC) through multiple mechanisms. …”
Get full text

Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma by Xiao-min Li, Shan-peng Liu, Yu Li, Xiao-ming Cai, Shao-bo Zhang, Ze-feng Xie

Subjects: Get full text

Novel insights into HBV‐hepatocellular carcinoma at single‐cell sequencing by Dandan Yin, Tao Zhou, Xuyang Xia, Chang Han, Zhaoqian Liu, Qiu Li, Yang Shu, Heng Xu

Subjects: Get full text

3D‐Epigenomic Regulation of Gene Transcription in Hepatocellular Carcinoma by Yuliang Feng, Ping Wang, Liuyang Cai, Meixiao Zhan, Fan He, Jiahui Wang, Yong Li, Eva Gega, Wei Zhang, Wei Zhao, Yongjie Xin, Xudong Chen, Yijun Ruan, Ligong Lu

Subjects: Get full text

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma by Meghan M. Bell, Nicholas T. Gutsche, A. Paden King, Kwamena E. Baidoo, Olivia J. Kelada, Peter L. Choyke, Freddy E. Escorcia

Subjects: Get full text